Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Inadvertent Administration of a Vaccine Following Temperature Excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. Co-suspect products included HBV (Engerix B) for prophylaxis, HAV (Havrix) for prophylaxis, DTPa (Infanrix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis and DTPa-HBV-IPV (Pediarix) for prophylaxis. On an unknown date, the patient received Boostrix, Engerix B, Havrix, Infanrix, Kinrix, Menveo and Pediarix. On an unknown date, an unknown time after receiving Boostrix, Engerix B, Havrix, Infanrix, Kinrix, Menveo and Pediarix, the patient experienced incorrect storage of drug (Verbatim: Inadvertent Administration of a Vaccine Following Temperature Excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:15-JUL-2025 Pharmacist reported that on 11th October 2024 Boostrix, Engerix-B, Havrix, Infanrix, Kinrix, Menveo (no lot number or data on presentation available) and Pediarix were exposed to a lowest temperature of 30.9F for less than 5 minutes. These vaccines have been administered to patients. HCP is trying to determine which are the patients involved. No further information available. No further information available. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.